Haematologica (Apr 2022)
A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials
- Min Yang,
- Wenhao Zhang,
- Kang Yu,
- Peng Wang,
- Hua Jiang,
- Linjun Chen,
- Haitao Meng,
- Yiqin Weng,
- Rong Tao,
- Xin Huang,
- Chongyun Xing,
- Huamao Wang,
- Jiangbo Wan,
- Shasha Wang,
- Lihui Dai,
- Amanda Y. Hendrix,
- Jun Xiao,
- Wei Wang,
- Hong Ma,
- Siguo Hao,
- Jie Jin,
- Zonghai Li,
- Songfu Jiang
Affiliations
- Min Yang
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
- Wenhao Zhang
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
- Kang Yu
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
- Peng Wang
- State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China; CARsgen Therapeutics Co. Ltd, Shanghai
- Hua Jiang
- CARsgen Therapeutics Co. Ltd, Shanghai
- Linjun Chen
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
- Haitao Meng
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
- Yiqin Weng
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
- Rong Tao
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
- Xin Huang
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
- Chongyun Xing
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
- Huamao Wang
- CARsgen Therapeutics Co. Ltd, Shanghai
- Jiangbo Wan
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
- Shasha Wang
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
- Lihui Dai
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
- Amanda Y. Hendrix
- CARsgen Therapeutics Corp., Houston, TX
- Jun Xiao
- CARsgen Therapeutics Co. Ltd, Shanghai
- Wei Wang
- CARsgen Therapeutics Co. Ltd, Shanghai
- Hong Ma
- CARsgen Therapeutics Corp., Houston, TX
- Siguo Hao
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
- Jie Jin
- The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
- Zonghai Li
- CARsgen Therapeutics Co. Ltd, Shanghai, China; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
- Songfu Jiang
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
- DOI
- https://doi.org/10.3324/haematol.2022.280629
- Journal volume & issue
-
Vol. 107,
no. 8
Abstract
No abstracts available.